The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Risk tables for parkinsonism and Parkinson’s disease
Abstract
We applied the incidence rates of parkinsonism and Parkinson's disease (PD) from Olmsted County, MN (1976-1990) to a hypothetical cohort undergoing the mortality rates observed in Minnesota, and computed the lifetime risk and the remaining lifetime risk of developing parkinsonism and PD. These risks were compared to cumulative incidences that do not take competing risks of death into account. The lifetime risk of developing parkinsonism from birth was 4.4% for men and 3.7% for women (ratio = 1.2). The corresponding risk of developing PD was 2.0% for men and 1.3% for women (ratio = 1.5). Because of the opposite effect of higher incidence and higher mortality rates in men, the lifetime risks were only slightly higher in men than in women. Lifetime cumulative incidences were consistently higher than lifetime risks; this difference was more pronounced in men and in older subjects. Lifetime risk estimates are useful in clinical practice, epidemiologic research, and public health.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“another study reported that two-thirds of AD patients are women [42].”
From Effect of Caffeine Consumption on the Risk for Neurological and Psychiatric Disorders: Sex Differences in Human (2020) · cites this paper as [42]
In the citing paper
“Overall, women showed higher incidence and prevalence of dementia than men, possibly due to various factors, such as longer life expectancy of women and different neuroanatomical function [42].”
From Effect of Caffeine Consumption on the Risk for Neurological and Psychiatric Disorders: Sex Differences in Human (2020) · cites this paper as [42]
Citations
Cites
History of the Rochester Epidemiology Project
Melton, L. J. (1996) · Mayo Clinic Proceedings · doi:10.4065/71.3.266 · Cited by 1,443
de Rijk, M. C., Tzourio, C., Breteler, M. M., Dartigues, J. F., Amaducci, L., Lopez-Pousa, S., Manubens-Bertran, J. M., Alperovitch, A., & Rocca, W. A. (1997) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.62.1.10 · Cited by 833
The Patient Record in Epidemiology
Kurland, L. T., & Molgaard, C. A. (1981) · Scientific American · doi:10.1038/scientificamerican1081-54 · Cited by 780
The Lifetime Risk of Developing Breast Cancer
Feuer, E. J., Wun, L., Boring, C. C., Flanders, W. D., Timmel, M. J., & Tong, T. (1993) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/85.11.892 · Cited by 640
Parkinson’s disease and parkinsonism in a longitudinal study: Two-fold higher incidence in men
Baldereschi, M., Di Carlo, A., Rocca, W. A., Vanni, P., Maggi, S., Perissinotto, E., Grigoletto, F., Amaducci, L., & Inzitari, D. (2000) · Neurology · doi:10.1212/wnl.55.9.1358 · Cited by 526
Incidence and distribution of parkinsonism in Olmsted County, Minnesota, 1976–1990
Bower, J. H., Maraganore, D. M., McDonnell, S. K., & Rocca, W. A. (1999) · Neurology · doi:10.1212/wnl.52.6.1214 · Cited by 509
Seshadri, S., Wolf, P. A., Beiser, A., Au, R., McNulty, K., White, R., & D'Agostino, R. B. (1997) · Neurology · doi:10.1212/wnl.49.6.1498 · Cited by 489
Incidence and Risk of Dementia: The Rotterdam study
Ott, A., Breteler, M. M. B., Harskamp, F. V., Stijnen, T., & Hofman, A. (1998) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009489 · Cited by 455
Mayeux, R. P., Marder, K. S., COTE, L. J., Denaro, J. E., Hemenegildo, N., Mejia‐Santana, H., Tang, M., Lantigua, R., Wilder, D., Gurland, B. J., et al. (1995) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a117721 · Cited by 387
Risk of Parkinson's disease among first-degree relatives
Marder, K. S., Tang, M., Mejía, H., Alfaro, B., Cote, L. J., Louis, E. K. S., Groves, J. T., & Mayeux, R. P. (1996) · Neurology · doi:10.1212/wnl.47.1.155 · Cited by 248
Cited by
Sorted by citations
The epidemiology of Parkinson's disease: risk factors and prevention
Ascherio, A., & Schwarzschild, M. A. (2016) · The Lancet Neurology · doi:10.1016/s1474-4422(16)30230-7 · Cited by 1,930
MDS research criteria for prodromal Parkinson's disease
Berg, D., Postuma, R. B., Adler, C. H., Bloem, B. R., Chan, P., Dubois, B., Gasser, T., Goetz, C. G., Halliday, G. M., Joseph, L., et al. (2015) · Movement Disorders · doi:10.1002/mds.26431 · Cited by 1,394
Epidemiology and etiology of Parkinson's disease: a review of the evidence
Wirdefeldt, K., Adami, H.-O., Cole, P., Trichopoulos, D., & Mandel, J. (2011) · European Journal of Epidemiology · doi:10.1007/s10654-011-9581-6 · Cited by 1,199
Description of Parkinson's Disease as a Clinical Syndrome
Fahn, S. (2003) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2003.tb07458.x · Cited by 979
Accurate Telemonitoring of Parkinson's Disease Progression by Noninvasive Speech TestsPreprint
Tsanas, A., Little, M. A., McSharry, P., & Ramig, L. O. (2009) · Nature Precedings · doi:10.1109/tbme.2009.2036000 · Cited by 833
Metadata
- Authors
- Elbaz, A., Bower, J. H., Maraganore, D. M., McDonnell, S. K., Peterson, B. J., Ahlskog, J. E., Schaid, D. J., & Rocca, W. A.
- Affiliations
- Mayo Clinic (US)
- Corresponding author
- Rocca, Walter A
- ORCID
- Venue
- Journal of Clinical Epidemiology
- Publisher
- Elsevier BV
- Published
- 2002-01
- Volume
- 55
- Issue
- 1
- Pages
- 25-31
- ISSN
- 0895-4356 (ISSN-L)
- OpenAlex
- W2013713870
- Cited by
- 377
- References
- 21
- Citations by year
- 2026: 6 · 2025: 15 · 2024: 21 · 2023: 14 · 2022: 20 · 2021: 16 · 2020: 21 · 2019: 25 · 2018: 32 · 2017: 18 · 2016: 23 · 2015: 19 · 2014: 21 · 2013: 10 · 2012: 12
- FWCI
- 5.31
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Clinical Epidemiology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Institut National de la Santé et de la Recherche Médicale
- National Institutes of Health
- National Institute of Neurological Disorders and Stroke (R01NS033978, NS33978)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01AR030582, AR30582)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Physical Sciences › Mathematics › Statistics and Probability › Statistical Methods in Epidemiology
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- Parkinson's disease, parkinsonism, lifetime risk, cumulative incidence, competing risk of death, incidence rates, mortality rates, sex differences, Olmsted County, Minnesota
- MeSH terms
- Adult, Aged, Female, Humans, Male, Middle Aged, Minnesota, Parkinson Disease, Risk Factors, Life Tables, Incidence, Age Distribution, Sex Distribution, Parkinsonian Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
